DRUG · Unmapped registry intervention
second- or third-line glucose-lowering diabetes treatment
Find medicine records ·
Find other trials using this name
Clinical trial
PROMASTER - PROspective Cohort MRC ABPI STratification and Extreme Response Mechanism in Diabetes
NCT02105792
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedPROMASTER - PROspective Cohort MRC ABPI STratification and Extreme Response Mechanism in Diabetes
Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Diabetesverified · MONDO: diabetes mellitus
Interventions
Sponsors & collaborators
Royal Devon and Exeter NHS Foundation Trustlead sponsor
University of Exetercollaborator
King's College Londoncollaborator
King's College Hospital NHS Trustcollaborator
University of Glasgowcollaborator
NHS Greater Glasgow and Clydecollaborator
Newcastle Universitycollaborator
Newcastle-upon-Tyne Hospitals NHS Trustcollaborator
Oxford University Hospitals NHS Trustcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02105792 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.